Virus Evolution · 2022 · 168 citations · 26 references
Life SciencesImmunologyInfectious DiseasesImmunizationMolecular VirologyVirologyAntibody DiscoveryAntibody-antigen RecognitionAntigen RecognitionVariant DetectionViral InfectionsAntibody Escape Variant MappingDeep Mutational ScanningExperimental CharacterizationMutational ScanningNeutralizing Antibody EscapePolyclonal AntibodiesPolyclonal Antibody RecognitionSars-cov-2 Variant Surveillance
A key goal of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) surveillance is to rapidly identify viral variants with mutations that reduce neutralization by polyclonal antibodies elicited by vaccination or infection. Unfortunately, direct experimental characterization of new viral variants lags their sequence-based identification. Here we help address this challenge by aggregating deep mutational scanning data into an 'escape estimator' that estimates the antigenic effects of arbitrary combinations of mutations to the virus's spike receptor-binding domain. The estimator can be used to intuitively visualize how mutations impact polyclonal antibody recognition and score the expected antigenic effect of combinations of mutations. These scores correlate with neutralization assays performed on SARS-CoV-2 variants and emphasize the ominous antigenic properties of the recently described Omicron variant. An interactive version of the estimator is at https://jbloomlab.github.io/SARS2_RBD_Ab_escape_maps/escape-calc/ (last accessed 11 March 2022), and we provide a Python module for batch processing. Currently the calculator uses primarily data for antibodies elicited by Wuhan-Hu-1-like vaccination or infection and so is expected to work best for calculating escape from such immunity for mutations relative to early SARS-CoV-2 strains.
26
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani, Christian Gaebler, Frauke Muecksch et al. · Nature · 2020 · 2.1K citations · Full text
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Christopher O. Barnes, Claudia A. Jette, Morgan E. Abernathy et al. · Nature · 2020 · 1.9K citations · Full text
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi, Chao Shan, Xiaomin Duan et al. · Nature · 2020 · 1.5K citations · Full text
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna K. Hansen, Alina Baum, Kristen E. Pascal et al. · Science · 2020 · 1.4K citations · Full text